#216 | Why Local Reference Sites Matter More Than Another Clinical Study (For MedTech Founders)

If your MedTech product already has strong clinical evidence, why are clinicians still hesitant to adopt it?Many MedTech founders assume that if adoption is slow, the answer is to generate more clinical evidence. But from a clinician's perspective, the real barrier is often confidence rather than proof. In this episode, Hakeem unpacks a real commercial decision with consultant cardiologist Dr Tang Wan, revealing why trusted local reference sites can have a greater influence on adoption than another published study, and how founders should use this insight to strengthen their commercialisation strategy.In this episode, you'll discover:Why clinicians don't always need more clinical evidence before adopting a new MedTech product.How trusted local reference sites reduce the perceived risk of adopting an innovative medical device.Why your first customers can become your most influential commercial asset by accelerating future adoption.Listen now to discover why trusted reference sites often matter more than additional clinical evidence and learn how to use your early customers to drive wider MedTech adoption.Book a 30min Healthcare Export Accelerator discovery callMessage me via DM on LinkedinThis podcast is for clinicians and solo founders feeling stuck in turning their medical devices into real businesses, with practical insight on go to market strategy, sales strategy, product launch, sales plans, business growth, exporting, selling internationally and how to scale up their international sales in MedTech.